Thanks terrible. Apreciate the answers. Love point 7 by the way....
Seeing as you seem to know this stock pretty well has anyone of authority ever spoken about expected first year sales estimates?
Lastly will there be any subsidising from governments etc or is this a "full cost to be worn by purchaser" scenario.
Looks like an exciting stock considering its low market cap, proven product and distribution network already in place!
Ann: US Clinical Trial Results Published, page-48
-
- There are more pages in this discussion • 32 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
